Skip to content

SEMM - Systematic Assessment of Menière's Disease: Prospective Observational Study

SEMM - Systematic Assessment of Menière's Disease: Prospective Observational Study - SEMM

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00027830
Enrollment
999
Registered
2022-03-28
Start date
2021-10-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H81.0

Interventions

Group 1: Observational study This is a monocentric study. Data is collected from the routine diagnostics and visits from the Menière’s Disease outpatient clinic. Visits are performed every 3, 6, 9, or

Sponsors

Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, LMU Klinikum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients with Menière's Disease who are treated in the neurotology outpatient clinic at the LMU Clinic and had given informed consent to participation in the study.

Exclusion criteria

Exclusion criteria: Vestibular migraines, other vestibular diseases.

Design outcomes

Primary

MeasureTime frame
Observational Study Primary and secondary endpoints will be assessed at the respective treatment intervals 3, 6, 9, or 12 months. Primary endpoints: - Classification for the Menière categories: probable, definitive Menière’s Disease, Menière characteristica - Treatment result and complications of the different treatment options - Course of disease - Change in quality of life Secondary endpoints: - Estimation of prognosis - Contentment of patients - Doctor patient relation

Secondary

MeasureTime frame
Treatment scheme

Countries

Germany

Contacts

Public ContactJennifer Spiegel

Klinik und Poliklinik für Hals-Nasen-OhrenheilkundeLMU Klinikum

jennifer.spiegel@med.uni-muenchen.de00498944000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026